Eupraxia Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
10 Sep 24 | BuyUS$5,139 | Michael Wilmink | Individual | 1,900 | US$2.73 | |
28 Jun 24 | BuyUS$37,848 | John Montalbano | Individual | 14,800 | US$2.56 | |
17 Jun 24 | BuyUS$2,926 | Michael Wilmink | Individual | 1,100 | US$2.66 | |
11 Jun 24 | BuyUS$2,248 | Michael Wilmink | Individual | 800 | US$2.81 | |
07 Jun 24 | BuyUS$2,730 | Michael Wilmink | Individual | 1,000 | US$2.73 | |
10 May 24 | BuyUS$1,920 | Michael Wilmink | Individual | 640 | US$3.00 |
Insider Trading Volume
Insider Buying: EPRX insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 1,793,090 | 5.03% |
Individual Insiders | 2,670,074 | 7.5% |
Hedge Funds | 2,784,049 | 7.82% |
General Public | 28,375,340 | 79.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 30.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,784,049 | US$7.2m | 0% | 21.82% | |||
1,367,051 | US$3.6m | 0% | 0.02% | |||
1,212,466 | US$3.2m | 1.24% | no data | |||
674,012 | US$1.8m | 0% | no data | |||
340,346 | US$885.2k | 0% | no data | |||
224,865 | US$584.8k | 0.85% | no data | |||
140,744 | US$366.1k | 0% | no data | |||
125,000 | US$325.1k | 0% | no data | |||
114,286 | US$297.2k | 0% | no data | |||
65,900 | US$171.4k | 17.9% | 0.01% | |||
49,250 | US$128.1k | 0% | no data | |||
46,343 | US$120.5k | 0% | no data | |||
29,590 | US$77.0k | 0% | no data | |||
27,200 | US$70.7k | 0% | no data | |||
13,930 | US$36.2k | 0% | no data | |||
13,000 | US$33.8k | 0% | 0.01% | |||
8,626 | US$22.4k | 0% | no data | |||
8,000 | US$20.8k | 0% | no data | |||
1,892 | US$4.9k | 0% | no data | |||
545 | US$1.4k | 0% | no data | |||
118 | US$305.7 | 0% | no data |